Identification of H, K, and N-ras point mutations in Stage IB cervical carcinoma

Gynecologic Oncology

Volumn 65, Issue 2, 1997, Pages 343-347

  Grendys Jr , E C ^a   Barnes, W A ^b   Weitzel, J ^c   Sparkowski, J ^b   Schlegel, R ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; FEMALE; HUMAN; HUMAN TISSUE; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 0031149585     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4649     Document Type: Article

References (29)

1. Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 54:1993;594.
2. Bauer H, Ting Y, Greer C, Chambers J. Genital human papillomavirus infection in female university students as determined by a PCR based method. JAMA. 265:1991;472.
3. Durst M, Gissmann L, Ikenberg H, Zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA. 80:1983;3812.
4. Lorincz A, Temple G, Kurman R, Lancaster W. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst. 79:1987;671.
5. Woodworth C, Bowden P, Doniger J, Pirisi L, Barnes W, Lancaster W, DiPaolo J. Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res. 48:1988;4620.
6. DiPaolo J, Woodwarth C, Popescu N, Notario J, Doniger J. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene. 4:1989;395.
7. G, M, Cooper, 1990, Oncogenes, Jones Bartlett, Boston.
8. Kumar R, Sukumar S, Barbacid M. Activation ofras. Science. 248:1990;1101-1104.
9. Slamon D, Dekernion J, Verma I, Cline M. Expression of cellular oncogenes in human malignancies. Science. 224:1984;256-262.
10. Bos J. The ras gene family and human carcinogenesis. Mutat Res. 195:1988;255.
11. Taparowsky E, Shimizu K, Goldfarb M, Wigler M. Structure and activation of the human N-ras gene. Cell. 34:1983;581-586.
12. Popescu N, Amsbaugh S, DiPaolo J, Aaronson S, Swan D. Chromosomal localization of three humanras. Somatic Cell Mol Genet. 11:1985;149.
13. Barbacid M. Ras genes. Annu Rev Biochem. 56:1987;779.
14. Tabin C, Bradley S, Bargmann C, Weinberg R. Mechanism of activation of a human oncogene. Nature. 300:1982;143-149.
15. McGrath J, Capon D, Goeddel D, Levinson A. Comparative biochemical properties of normal and activated human ras p21 protein. Nature. 310:1984;644.
16. Wong Y, Chung T, Cheung T, Lam S, Xu Y, Chang A. Frequentras. CA Lett. 95:1995;29-32.
17. Lee J, Lee S, Yang M, Ahmed M, Mohiuddin M, Lee E. Expression and mutation of H-ras in uterine cervical cancer. Gynecol Oncol. 62:1995;49-54.
18. Sagae S, Kuzumake N, Hisada T, Mugikura Y, Kudo R, Hashimoto M. Ras. CA. 63:1989;1577-1582.
19. Koulos J, Wright T, Mitchell M, Silva E, Atkinson E, Richart R. Relationships between c-Ki-ras mutations, HPV types and prognostic indicators in invasive endocervical adenocarcinomas. Gynecol Oncol. 48:1993;364-369.
20. Willis G, Jennings B, Ball R, New N, Gibson I. Analysis ofras. Gynecol Oncol. 49:1992;359-364.
21. Iwasaka T, Yokoyama M, Oh-Uchida M, Matusuo N, Hara K, Fukuyama K, Hachisuga T, Fukuda K, Sugimori H. Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas. Gynecol Oncol. 46:1992;298-303.
22. Le L, Stoerker J, Rinehart C, Fowler W. H-ras. Gynecol Oncol. 49:1993;181-184.
23. Burnett A, Barnes W, Johnson J, Grendys E, Willett G, Barter J, Doniger J. Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer. Gynecol Oncol. 47:1992;343-347.
24. Wallace R, Miyada C. Stringency conditions in dot blot hybridization. Methods Enzymol. 152:1990;438.
25. Peters R, Thomas D, Hagan D, Mack T, Henderson B. Risk factors for invasive cervical carcinoma. J Natl Cancer Inst. 77:1986;1063.
26. Gallick G, Kurzrock R, Kloetzer W, Arlinghaus R, Gutterman J. Expression of ras p21 in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci USA. 82:1985;1795-1799.
27. Sagae S, Kudo R, Kuzumaki N, Hisada T, Mugikura Y, Nihei T, Takeda T, Hasimoto M. Ras. Cancer. 66:1990;295-301.
28. Pinion S, Miller R, Kennedy J, MacLean A. Oncogene expression cervical intraepithelial neoplasia and invasive cancer of cervix. Lancet. 337:1991;819-820.
29. Der C, Finkel T, Cooper G. Biological and biochemical properties of humanras. Cell. 55:1986;167-176.